View Clinical Trial (Medical Research Study)

Review of Safety Using Rilonacept in Preventing Gout Exacerbations (RE-SURGE) - NCT00856206-(Clinical Trial 275890)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Wauwatosa
State:  
WI
Zip Code:
Conditions: Gout
Purpose: The purpose of this clinical research study is to determine the safety and effectiveness of an experimental drug called rilonacept in subjects with gout who are on urate-lowering therapy. Subjects will participate in this study for approximately 20 weeks. Rilonacept is being studied for use in preventing gout flares in subjects on urate-lowering therapy.
Study summary:
Criteria: Inclusion Criteria: - Male or female 18 to 80 years of age - Previously met the preliminary criteria of ARA for the classification of acute gout arthritis of primary gout - Subjects with history of gout, initiating or currently on urate lowering therapy who are at risk of gout flare Exclusion Criteria: - Acute gout flare within 2 weeks prior to the Screening Visit and during the screening visit - Persistent chronic or active infections - History of an allergic reaction to allopurinol - History or presence of cancer within 5 years of the Screening Visit
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: January 6, 2011
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.